Individuals with Fontan circulation are at risk of late mortality from both cardiac and noncardiac causes. Despite the known risk of mortality, referral indications for advanced heart failure care ...
Ultimately, Dr. Minn notes, success in immuno-oncology will be measured in multiple ways: Scientifically, by the depth of ...
FDA drug approvals are reshaping biotech stocks—track key decisions, FDA leadership turmoil, and volatility. Click for a look ...
The safety evidence from TRAVERSE refers to men with confirmed low testosterone levels — below 300 nanograms per decilitre of ...
Chris Brickler explains in an interview how Mynd Immersive sees VR therapy’s potential to support veterans facing pain and ...
3d
Medicaid fraud fears grow amid massive red state billing spike in sector that also plagued Minnesota
North Carolina's state auditor says a massive surge in Medicaid autism therapy billings signals potential waste, fraud, and ...
Psychedelic-assisted therapy is the subject of renewed focus. It involves using psilocybin—a substance found in psychoactive ...
Mental health clinicians have started asking clients how they use generative artificial intelligence chatbots to support ...
Nearly every woman with breast cancer has at least one menopausal symptom. Yet many patients feel their quality-of-life needs ...
College students with anxiety, depression and eating disorders may be more likely to start and to respond more positively to ...
In this episode, the panel considers safety questions surrounding OX40-targeted therapy in light of the Kaposi sarcoma (KS) ...
MPR spoke with Dr Daniela Carvalho, an investigator in the CHORD trial, the results form which formed the basis for the approval of Otarmeni.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results